Sontag Advisory »

Ishares Tr genomics immun shares owned by Sontag Advisory

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $534 23 23.22

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Ishares Tr genomics immun

UBS Group
Wharton Business Group
Raymond James Financial
Morgan Stanley
Portland Global Advisors
Ameriprise Financial
Royal Bank of Canada
Jane Street
LPL Financial
Bsc Private Wealth Management
Lido Advisors
Nelson, Van Denburg & Campbell Wealth Management
Commonwealth Equity Services
Flow Traders US
Cambridge Investment Research Advisors

View all funds holding Ishares Tr genomics immun